Down-regulation of Fibulin-5 is associated with aortic dilation: Role of inflammation and epigenetics

Cardiovascular Research

Volumn 110, Issue 3, 2016, Pages 431-442

  Orriols, Mar ^a   Varona, Saray ^a   Martí Pàmies, Ingrid ^a   Galán, María ^a   Guadall, Anna ^a   Escudero, José Román ^b   Martín Ventura, José Luis ^c   Camacho, Mercedes ^b   Vila, Luis ^b   Martínez González, José ^a   Rodríguez, Cristina ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b II B Sant Pau   (Spain)

^c UAM)   (Spain)

Author keywords

Abdominal aortic aneurysm; Fibulin 5; Histone deacetylases; SOX9; Vascular smooth muscle cells

Indexed keywords

CYTOKINE; ENTINOSTAT; FIBULIN 5; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE INHIBITOR; LIPOPOLYSACCHARIDE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; ANGIOTENSIN II; AUTACOID; FBLN5 PROTEIN, HUMAN; FBLN5 PROTEIN, MOUSE; RECOMBINANT PROTEIN; SCLEROPROTEIN; SOX9 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX9; TUMOR NECROSIS FACTOR;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ELASTIC FIBER; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; ABDOMINAL AORTA; ABDOMINAL AORTIC ANEURYSM; ANIMAL; BINDING SITE; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENETIC EPIGENESIS; GENETIC TRANSFECTION; GENETICS; LESIONS AND DEFECTS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; BINDING SITES; CASE-CONTROL STUDIES; CELLS, CULTURED; DILATATION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPIGENESIS, GENETIC; EXTRACELLULAR MATRIX PROTEINS; HISTONE DEACETYLASE INHIBITORS; HUMANS; INFLAMMATION MEDIATORS; MALE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; RNA INTERFERENCE; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84973316206     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvw082     Document Type: Article

References (46)

1. Weintraub NL. Understanding abdominal aortic aneurysm. N Engl J Med 2009;361: 1114-1116.
2. Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 2011;8:92-102.
3. Loscalzo J, Handy DE. Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series). Pulm Circ 2014;4:169-174.
4. Hodawadekar SC, Marmorstein R. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design. Oncogene 2007; 26:5528-5540.
5. Pons D, de Vries FR, van den Elsen PJ, Heijmans BT, Quax PH, Jukema JW. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur Heart J 2009;30:266-277.
6. Wang L, de Zoeten EF, Greene MI, HancockWW. Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells. Nat Rev Drug Discov 2009;8:969-981.
7. Natarajan R. Drugs targeting epigenetic histone acetylation in vascular smooth muscle cells for restenosis and atherosclerosis. Arterioscler Thromb Vasc Biol 2011;31:725-727.
8. Eom GH, Kook H. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases. Pharmacol Ther 2014;143:168-180.
9. Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S, Cheng CF, Kobuke K, Dalton N, Takada Y, Tashiro K, Ross Jr J, Honjo T, Chien KR. FBLN5/ DANCE is essential for elastogenesis in vivo. Nature 2002;415:171-175.
10. Yanagisawa H, Davis EC, Starcher BC, Ouchi T, Yanagisawa M, Richardson JA, Olson EN. FBLN5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 2002;415:168-171.
11. Nakamura T, Ruiz-Lozano P, Lindner V, Yabe D, Taniwaki M, Furukawa Y, Kobuke K, Tashiro K, Lu Z, Andon NL, Schaub R, Matsumori A, Sasayama S, Chien KR, Honjo T. DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J Biol Chem 1999;274:22476-22483.
12. Lomas AC, Mellody KT, Freeman LJ, Bax DV, Shuttleworth CA, Kielty CM. Fibulin-5 binds human smooth-muscle cells through alpha5beta1 and alpha4beta1 integrins, but does not support receptor activation. Biochem J 2007;405:417-428.
13. Spencer JA, Hacker SL, Davis EC, Mecham RP, Knutsen RH, Li DY, Gerard RD, Richardson JA, Olson EN. Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc Natl Acad Sci USA 2005;102:2946-2951.
14. Preis M, Cohen T, Sarnatzki Y, Ben Yosef Y, Schneiderman J, Gluzman Z, Koren B, Lewis BS, Shaul Y, Flugelman MY. Effects of fibulin-5 on attachment, adhesion, and proliferation of primary human endothelial cells. Biochem Biophys Res Commun 2006;348: 1024-1033.
15. Kapustin A, Stepanova V, Aniol N, Cines DB, Poliakov A, Yarovoi S, Lebedeva T,Wait R, Ryzhakov G, Parfyonova Y, Gursky Y, Yanagisawa H, Minashkin M, Beabealashvilli R, Vorotnikov A, Bobik A, Tkachuk V. Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated b1-integrin-dependent cell migration. Biochem J 2012;443:491-503.
16. Guadall A, Orriols M, Rodríguez-Calvo R, Calvayrac O, Crespo J, Aledo R, Martínez-González J, Rodríguez C. Fibulin-5 is up-regulated by hypoxia in endothelial cells through a hypoxia-inducible Factor-1 (HIF-1a)-dependent Mechanism. J Biol Chem 2011;286:7093-7103.
17. Chapman SL, Sicot FX, Davis EC, Huang J, Sasaki T, Chu ML, Yanagisawa H. Fibulin-2 and fibulin-5 cooperatively function to form the internal elastic lamina and protect from vascular injury. Arterioscler Thromb Vasc Biol 2010;30:68-74.
18. Camacho M, DilméJ, Sola-Villa D, Bellmunt S, Siguero L, Alcolea S, Romero JM, Escudero JR, Martínez-González J, Vila L. Microvascular COX-2/mPGES-1/EP-4 axis in human abdominal aortic aneurysm. J Lipid Res 2013;54:3506-3515.
19. Martinez-Pinna R, Madrigal-Matute J, Tarin C, Burillo E, Esteban-Salan M, Pastor-Vargas C, Lindholt JS, Lopez JA, Calvo E, de Ceniga MV, Meilhac O, Egido J, Blanco-Colio LM, Michel JB, Martin-Ventura JL. Proteomic analysis of intraluminal thrombus highlights complement activation in human abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2013;33:2013-2020.
20. Calvayrac O, Rodríguez-Calvo R, Martí-Pamies I, Alonso J, Ferrán B, AguilóS, Crespo J, Rodríguez-Sinovas A, Rodríguez C, Martínez-González J. NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFkB activation. J Mol Cell Cardiol 2015;80:34-44.
21. Spallotta F, Tardivo S, Nanni S, Rosati JD, Straino S, Mai A, Vecellio M, Valente S, Capogrossi MC, Farsetti A, Martone J, Bozzoni I, Pontecorvi A, Gaetano C, Colussi C. Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia. J Biol Chem 2013;288:22915-22929.
22. Rius J, Martínez-González J, Crespo J, Badimon L. Involvement of neuron-derived orphan receptor-1 (NOR-1) in LDL-induced mitogenic stimulus in vascular smooth muscle cells: role of CREB. Arterioscler Thromb Vasc Biol 2004;24:697-702.
23. Calvayrac O, Rodríguez-Calvo R, Alonso J, Orbe J, Martín-Ventura JL, Guadall A, Gentile M, Juan-Babot O, Egido J, Beloqui O, Paramo JA, Rodríguez C, Martínez-González J. CCL20 is increased in hypercholesterolemic subjects and is upregulated by LDL in vascular smooth muscle cells: role of NF-kB. Arterioscler Thromb Vasc Biol 2011;31:2733-2741.
24. Brandsma C-A, van den Berge M, Postma DS. A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD. Thorax 2015;70:21-32.
25. Akiyama H, Kim J-E, Nakashima K, Balmes G, Iwai N, Deng JM, Zhang Z, Martin JF, Behringer RR, Nakamura T, de Crombrugghe B. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci USA 2005;102: 14665-14670.
26. Oh C, Maity SN, Lu J-F, Zhang J, Liang S, Coustry F, de Crombrugghe B, Yasuda H. Identification of SOX9 interaction sites in the genome of chondrocytes. PLoS ONE 2010;5: e10113.
27. Hanley KP, Oakley F, Sugden S, Wilson DI, Mann DA, Hanley NA. Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem 2008; 283:14063-14071.
28. Liu S, Cheng H, Kwan W, Lubieniecka JM, Nielsen TO. Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models. Mol Cancer Ther 2008;7:1751-1761.
29. Wang JP,Wen MH, Chen YT, Lee HH, Chiang ER, Lee YT, Liu CL, Chen TH, Hung SC. Trichostatin A inhibits TGF-b1 induced in vitro chondrogenesis of hMSCs through Sp1 suppression. Differentiation 2011;81:119-126.
30. Loeys B, Van Maldergem L, Mortier G, Coucke P, Gerniers S, Naeyaert JM, De Paepe A. Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet 2002;11:2113-2118.
31. Stone EM, Braun TA, Russell SR, Kuehn MH, Lotery AJ, Moore PA, Eastman CG, Casavant TL, Sheffield VC. Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 2004;351:346-353.
32. Budatha M, Roshanravan S, Zheng Q,Weislander C, Chapman SL, Davis EC, Starcher B, Word RA, Yanagisawa H. Extracellular matrix proteases contribute to progression of pelvic organ prolapse in mice and humans. J Clin Invest 2011;121:2048-2059.
33. YueW, Sun Q, Landreneau R, Wu C, Siegfried JM, Yu J, Zhang L. Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression. Cancer Res 2009;69:6339-6346.
34. Stempelj M, Kedinger M, Augenlicht L, Klampfer L. Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J Biol Chem 2007;282:9797-9804.
35. Thangjam GS, Dimitropoulou C, Joshi AD, Barabutis N, Shaw MC, Kovalenkov Y, Wallace CM, Fulton DJ, Patel V, Catravas JD. Novel mechanism of attenuation of LPS-induced NF-kB activation by the heat shock protein 90 inhibitor, 17-N-allylamino-17-demethoxygeldanamycin, in human lung microvascular endothelial cells. Am J Respir Cell Mol Biol 2014;50:942-952.
36. Turner BM. Decoding the nucleosome. Cell 1993;75:5-8.
37. Qu X, Pröll M, Neuhoff C, Zhang R, Cinar MU, Hossain MM, Tesfaye D, Große-Brinkhaus C, Salilew-Wondim D, Tholen E, Looft C, Hölker M, Schellander K, Uddin MJ. Sulforaphane epigenetically regulates innate immune responses of porcine monocyte-derived dendritic cells induced with lipopolysaccharide. PLoS ONE 2015; 10:e0121574.
38. Mehta A, Ravinder, Onteru SK, Singh D. HDAC inhibitor prevents LPS mediated inhibition of CYP19A1 expression and 17b-estradiol production in granulosa cells. Mol Cell Endocrinol 2015;414:73-81.
39. Kuang PP, Joyce-Brady M, Zhang X-H, Jean JC, Goldstein RH. Fibulin-5 gene expression in human lung fibroblasts is regulated by TGF-beta and phosphatidylinositol 3-kinase activity. Am J Physiol Cell Physiol 2006;291:C1412-C1421.
40. García-Ramírez M, Martínez-González J, Juan-Babot JO, Rodríguez C, Badimon L. Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth. Arterioscler Thromb Vasc Biol 2005; 25:2398-2403.
41. Castillo SD, Sanchez-Cespedes M. The SOX family of genes in cancer development: biological relevance and opportunities for therapy. Expert Opin Ther Targets 2012;16: 903-919.
42. Lincoln J, Kist R, Scherer G, Yutzey KE. Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev Biol 2007;305:120-132.
43. Wang L, He S, Yuan J, Mao X, Cao Y, Zong J, Tu Y, Zhang Y. Oncogenic role of SOX9 expression in human malignant glioma. Med Oncol 2012;29:3484-3490.
44. Piera-Velazquez S, Hawkins DF, Whitecavage MK, Colter DC, Stokes DG, Jimenez SA. Regulation of the human SOX9 promoter by Sp1 and CREB. Exp Cell Res 2007;313: 1069-1079.
45. Murakami S, Lefebvre V, de Crombrugghe B. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem 2000;275:3687-3692.
46. Galán M, Varona S, Orriols M, Rodríguez JA, AguilóS, DilméJ, Camacho M, Martínez-González J, Rodriguez C. Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors. Dis Model Mech 2016.